AlphaStocks
3.3
Weak

Privia Health Group, Inc. (PRVA)

As of Sep 19, 2026, Privia Health Group, Inc. (PRVA) scores 3.3/10 on AlphaStocks' five-model composite, #153 of 168 Health Care stocks.

Health Care / Health Care Services

S&P SmallCap 600

$19.84

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#153out of 168 in Health Care

Is Privia Health Group, Inc. a Good Investment in 2026?

Privia Health Group, Inc. (PRVA) scores 3.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Privia Health Group, Inc. as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. Privia Health Group, Inc. ranks #153 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E111.6ROE3.2Market Cap3B

Valuation

Trades at 112x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Attractive

High PEG — growth premium · Stalwart

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Privia Health Group, Inc. (PRVA) a good investment?
As of Sep 19, 2026, Privia Health Group, Inc. (PRVA) scores 3.3/10 on AlphaStocks' five-model composite, #153 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 112x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
What is Privia Health Group, Inc.'s Piotroski F-Score?
Privia Health Group, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PRVA overvalued or undervalued?
A precise fair value estimate is not available for PRVA. Trades at 112x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
How does PRVA compare to other Health Care stocks?
Privia Health Group, Inc. ranks #153 out of 168 stocks in the Health Care sector, placing it in the top 91% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PRVA?
AlphaStocks evaluates PRVA using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Attractive. These models are combined into a single composite score of 3.3/10.

Similar Stocks

DVAMDDGX

Compare PRVA with

DVA vs PRVAMD vs PRVADGX vs PRVA

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer